Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34


Persistent Infection of African Buffalo (Syncerus caffer) with Foot-and-Mouth Disease Virus: Limited Viral Evolution and No Evidence of Antibody Neutralization Escape.

Cortey M, Ferretti L, Pérez-Martín E, Zhang F, de Klerk-Lorist LM, Scott K, Freimanis G, Seago J, Ribeca P, van Schalkwyk L, Juleff ND, Maree FF, Charleston B.

J Virol. 2019 Jul 17;93(15). pii: e00563-19. doi: 10.1128/JVI.00563-19. Print 2019 Aug 1.


Chimeric O1K foot-and-mouth disease virus with SAT2 outer capsid as an FMD vaccine candidate.

Kotecha A, Perez-Martin E, Harvey Y, Zhang F, Ilca SL, Fry EE, Jackson B, Maree F, Scott K, Hecksel CW, Harmsen MM, Mioulet V, Wood B, Juleff N, Stuart DI, Charleston B, Seago J.

Sci Rep. 2018 Sep 12;8(1):13654. doi: 10.1038/s41598-018-31856-x.


Within-Host Recombination in the Foot-and-Mouth Disease Virus Genome.

Ferretti L, Di Nardo A, Singer B, Lasecka-Dykes L, Logan G, Wright CF, Pérez-Martín E, King DP, Tuthill TJ, Ribeca P.

Viruses. 2018 Apr 25;10(5). pii: E221. doi: 10.3390/v10050221.


Detection of Pathogen Exposure in African Buffalo Using Non-Specific Markers of Inflammation.

Glidden CK, Beechler B, Buss PE, Charleston B, de Klerk-Lorist LM, Maree FF, Muller T, Pérez-Martin E, Scott KA, van Schalkwyk OL, Jolles A.

Front Immunol. 2018 Jan 11;8:1944. doi: 10.3389/fimmu.2017.01944. eCollection 2017.


A replication-competent foot-and-mouth disease virus expressing a luciferase reporter.

Zhang F, Perez-Martin E, Juleff N, Charleston B, Seago J.

J Virol Methods. 2017 Sep;247:38-44. doi: 10.1016/j.jviromet.2017.05.011. Epub 2017 May 19.


Combination of Adt-O1Manisa and Ad5-boIFNλ3 induces early protective immunity against foot-and-mouth disease in cattle.

Diaz-San Segundo F, Montiel NA, Sturza DF, Perez-Martin E, Hickman D, Ramirez-Medina E, Grubman MJ, de Los Santos T.

Virology. 2016 Dec;499:340-349. doi: 10.1016/j.virol.2016.09.027. Epub 2016 Oct 12.


Type I and III IFNs Produced by Plasmacytoid Dendritic Cells in Response to a Member of the Flaviviridae Suppress Cellular Immune Responses.

Reid E, Juleff N, Windsor M, Gubbins S, Roberts L, Morgan S, Meyers G, Perez-Martin E, Tchilian E, Charleston B, Seago J.

J Immunol. 2016 May 15;196(10):4214-26. doi: 10.4049/jimmunol.1600049. Epub 2016 Apr 6.


Differential Persistence of Foot-and-Mouth Disease Virus in African Buffalo Is Related to Virus Virulence.

Maree F, de Klerk-Lorist LM, Gubbins S, Zhang F, Seago J, Pérez-Martín E, Reid L, Scott K, van Schalkwyk L, Bengis R, Charleston B, Juleff N.

J Virol. 2016 Apr 29;90(10):5132-5140. doi: 10.1128/JVI.00166-16. Print 2016 May 15.


Structure-based energetics of protein interfaces guides foot-and-mouth disease virus vaccine design.

Kotecha A, Seago J, Scott K, Burman A, Loureiro S, Ren J, Porta C, Ginn HM, Jackson T, Perez-Martin E, Siebert CA, Paul G, Huiskonen JT, Jones IM, Esnouf RM, Fry EE, Maree FF, Charleston B, Stuart DI.

Nat Struct Mol Biol. 2015 Oct;22(10):788-94. doi: 10.1038/nsmb.3096. Epub 2015 Sep 21.


Poly ICLC increases the potency of a replication-defective human adenovirus vectored foot-and-mouth disease vaccine.

Diaz-San Segundo F, Dias CC, Moraes MP, Weiss M, Perez-Martin E, Salazar AM, Grubman MJ, de Los Santos T.

Virology. 2014 Nov;468-470:283-292. doi: 10.1016/j.virol.2014.08.012. Epub 2014 Sep 12.


Laboratory animal models to study foot-and-mouth disease: a review with emphasis on natural and vaccine-induced immunity.

Habiela M, Seago J, Perez-Martin E, Waters R, Windsor M, Salguero FJ, Wood J, Charleston B, Juleff N.

J Gen Virol. 2014 Nov;95(Pt 11):2329-45. doi: 10.1099/vir.0.068270-0. Epub 2014 Jul 7. Review.


Type III interferon protects swine against foot-and-mouth disease.

Perez-Martin E, Diaz-San Segundo F, Weiss M, Sturza DF, Dias CC, Ramirez-Medina E, Grubman MJ, de los Santos T.

J Interferon Cytokine Res. 2014 Oct;34(10):810-21. doi: 10.1089/jir.2013.0112. Epub 2014 Apr 30.


Venezuelan equine encephalitis replicon particles can induce rapid protection against foot-and-mouth disease virus.

Diaz-San Segundo F, Dias CC, Moraes MP, Weiss M, Perez-Martin E, Owens G, Custer M, Kamrud K, de los Santos T, Grubman MJ.

J Virol. 2013 May;87(10):5447-60. doi: 10.1128/JVI.03462-12. Epub 2013 Mar 6.


BacMam immunization partially protects pigs against sublethal challenge with African swine fever virus.

Argilaguet JM, Pérez-Martín E, López S, Goethe M, Escribano JM, Giesow K, Keil GM, Rodríguez F.

Antiviral Res. 2013 Apr;98(1):61-5. doi: 10.1016/j.antiviral.2013.02.005. Epub 2013 Feb 18.


Head-to-head comparison of three vaccination strategies based on DNA and raw insect-derived recombinant proteins against Leishmania.

Todolí F, Rodríguez-Cortés A, Núñez Mdel C, Laurenti MD, Gómez-Sebastián S, Rodríguez F, Pérez-Martín E, Escribano JM, Alberola J.

PLoS One. 2012;7(12):e51181. doi: 10.1371/journal.pone.0051181. Epub 2012 Dec 7.


DNA vaccination partially protects against African swine fever virus lethal challenge in the absence of antibodies.

Argilaguet JM, Pérez-Martín E, Nofrarías M, Gallardo C, Accensi F, Lacasta A, Mora M, Ballester M, Galindo-Cardiel I, López-Soria S, Escribano JM, Reche PA, Rodríguez F.

PLoS One. 2012;7(9):e40942. doi: 10.1371/journal.pone.0040942. Epub 2012 Sep 26.


Evaluation of cell-mediated immune responses against porcine circovirus type 2 (PCV2) Cap and Rep proteins after vaccination with a commercial PCV2 sub-unit vaccine.

Fort M, Sibila M, Nofrarías M, Pérez-Martín E, Olvera A, Mateu E, Segalés J.

Vet Immunol Immunopathol. 2012 Nov 15;150(1-2):128-32. doi: 10.1016/j.vetimm.2012.09.001. Epub 2012 Sep 5.


Novel antiviral therapeutics to control foot-and-mouth disease.

Dias CC, Moraes MP, Weiss M, Diaz-San Segundo F, Perez-Martin E, Salazar AM, de los Santos T, Grubman MJ.

J Interferon Cytokine Res. 2012 Oct;32(10):462-73. doi: 10.1089/jir.2012.0012. Epub 2012 Aug 27.


Bovine type III interferon significantly delays and reduces the severity of foot-and-mouth disease in cattle.

Perez-Martin E, Weiss M, Diaz-San Segundo F, Pacheco JM, Arzt J, Grubman MJ, de los Santos T.

J Virol. 2012 Apr;86(8):4477-87. doi: 10.1128/JVI.06683-11. Epub 2012 Feb 1.


Inoculation of swine with foot-and-mouth disease SAP-mutant virus induces early protection against disease.

Segundo FD, Weiss M, Pérez-Martín E, Dias CC, Grubman MJ, Santos Tde L.

J Virol. 2012 Feb;86(3):1316-27. doi: 10.1128/JVI.05941-11. Epub 2011 Nov 23.


EUS-guided single-incision needle-knife biopsy: description and results of a new method for tissue sampling of subepithelial GI tumors (with video).

de la Serna-Higuera C, Pérez-Miranda M, Díez-Redondo P, Gil-Simón P, Herranz T, Pérez-Martín E, Ochoa C, Caro-Patón A.

Gastrointest Endosc. 2011 Sep;74(3):672-6. doi: 10.1016/j.gie.2011.05.042.


A DNA vaccine encoding foot-and-mouth disease virus B and T-cell epitopes targeted to class II swine leukocyte antigens protects pigs against viral challenge.

Borrego B, Argilaguet JM, Pérez-Martín E, Dominguez J, Pérez-Filgueira M, Escribano JM, Sobrino F, Rodriguez F.

Antiviral Res. 2011 Nov;92(2):359-63. doi: 10.1016/j.antiviral.2011.07.017. Epub 2011 Jul 26.


Enhancing DNA immunization by targeting ASFV antigens to SLA-II bearing cells.

Argilaguet JM, Pérez-Martín E, Gallardo C, Salguero FJ, Borrego B, Lacasta A, Accensi F, Díaz I, Nofrarías M, Pujols J, Blanco E, Pérez-Filgueira M, Escribano JM, Rodríguez F.

Vaccine. 2011 Jul 26;29(33):5379-85. doi: 10.1016/j.vaccine.2011.05.084. Epub 2011 Jun 14.


Antiviral activity of bovine type III interferon against foot-and-mouth disease virus.

Díaz-San Segundo F, Weiss M, Perez-Martín E, Koster MJ, Zhu J, Grubman MJ, de los Santos T.

Virology. 2011 May 10;413(2):283-92. doi: 10.1016/j.virol.2011.02.023. Epub 2011 Mar 24.


Porcine circovirus type 2 (PCV2) Cap and Rep proteins are involved in the development of cell-mediated immunity upon PCV2 infection.

Fort M, Sibila M, Nofrarías M, Pérez-Martín E, Olvera A, Mateu E, Segalés J.

Vet Immunol Immunopathol. 2010 Oct 15;137(3-4):226-34. doi: 10.1016/j.vetimm.2010.05.013. Epub 2010 Jun 1.


Immunity conferred by an experimental vaccine based on the recombinant PCV2 Cap protein expressed in Trichoplusia ni-larvae.

Pérez-Martín E, Gómez-Sebastián S, Argilaguet JM, Sibila M, Fort M, Nofrarías M, Kurtz S, Escribano JM, Segalés J, Rodríguez F.

Vaccine. 2010 Mar 8;28(11):2340-9. doi: 10.1016/j.vaccine.2009.12.061. Epub 2010 Jan 5.


Interferon-gamma induction correlates with protection by DNA vaccine expressing E2 glycoprotein against classical swine fever virus infection in domestic pigs.

Tarradas J, Argilaguet JM, Rosell R, Nofrarías M, Crisci E, Córdoba L, Pérez-Martín E, Díaz I, Rodríguez F, Domingo M, Montoya M, Ganges L.

Vet Microbiol. 2010 Apr 21;142(1-2):51-8. doi: 10.1016/j.vetmic.2009.09.043. Epub 2009 Sep 30.


One dose of a porcine circovirus 2 (PCV2) sub-unit vaccine administered to 3-week-old conventional piglets elicits cell-mediated immunity and significantly reduces PCV2 viremia in an experimental model.

Fort M, Sibila M, Pérez-Martín E, Nofrarías M, Mateu E, Segalés J.

Vaccine. 2009 Jun 19;27(30):4031-7. doi: 10.1016/j.vaccine.2009.04.028. Epub 2009 May 3.


Anti-HEV antibodies in domestic animal species and rodents from Spain using a genotype 3-based ELISA.

Peralta B, Casas M, de Deus N, Martín M, Ortuño A, Pérez-Martín E, Pina S, Mateu E.

Vet Microbiol. 2009 May 28;137(1-2):66-73. doi: 10.1016/j.vetmic.2009.01.006. Epub 2009 Jan 7.


Development of two Trichoplusia ni larvae-derived ELISAs for the detection of antibodies against replicase and capsid proteins of porcine circovirus type 2 in domestic pigs.

Pérez-Martín E, Grau-Roma L, Argilaguet JM, Nofrarías M, Escribano JM, Gómez-Sebastián S, Segalés J, Rodríguez F.

J Virol Methods. 2008 Dec;154(1-2):167-74. doi: 10.1016/j.jviromet.2008.07.034. Epub 2008 Sep 21.


A new method to identify cell types that support porcine circovirus type 2 replication in formalin-fixed, paraffin-embedded swine tissues.

Pérez-Martín E, Rovira A, Calsamiglia M, Mankertz A, Rodríguez F, Segalés J.

J Virol Methods. 2007 Dec;146(1-2):86-95. Epub 2007 Jul 20.


Liver metastases from uveal melanoma.

Sánchez-Pobre P, Pérez Martín E, López Alonso G, Sáenz-López S, Martínez-Montiel P, Fernández I, Solís-Herruzo JA.

Rev Esp Enferm Dig. 2005 Apr;97(4):287-9. English, Spanish. No abstract available.


Evidence of potential gene flow in Trichinella spiralis and in Trichinella britovi in nature.

Pozio E, Serrano FJ, La Rosa G, Reina D, Perez-Martin E, Navarrete I.

J Parasitol. 1997 Feb;83(1):163-6.


[Experience with preverbal psychotherapy in a group of chronic psychotic patients].

Angosto Saura T, García Gómez M, Pérez Martín E, Alonso Seijo MM, Diz Quinteiro B, Formoso Caamaño ML, Molinos Louro MA, Vicente Vázquez M.

Actas Luso Esp Neurol Psiquiatr Cienc Afines. 1984 May-Jun;12(3):215-22. Spanish. No abstract available.


Supplemental Content

Loading ...
Support Center